FIBROBIOLOGICS INC. -

2.8500

25-11月-24 16:45:01

15 分の遅延

株式

+0.2500

+9.62%

本日の幅

2.5200 - 2.9800

ISIN

N/A

ソース

NASDAQ

FibroBiologics to Present at the BIO International Convention 2024

07 5 2024 09:31:00 提供 Nasdaq GlobeNewswire
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

25 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

11 4 2024 09:31:00 提供 Nasdaq GlobeNewswire
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

04 4 2024 09:31:00 提供 Nasdaq GlobeNewswire
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

28 3 2024 09:31:00 提供 Nasdaq GlobeNewswire

<<
<
1
2
>

同意します NetDania's website uses cookies. By continuing browsing our website, you agree to our クッキー方針, 個人情報保護方針 and 利用規約.